For research use only. Not for therapeutic Use.
iGP-1 (CAT: I012561) is a novel cell-permeant inhibitor targeting mitochondrial sn-glycerol 3-phosphate dehydrogenase. Through its mechanism of action, iGP-1 disrupts the function of this enzyme involved in glycerolipid metabolism within mitochondria. By inhibiting the activity of sn-glycerol 3-phosphate dehydrogenase, iGP-1 has the potential to modulate cellular processes that rely on glycerolipid metabolism. This compound’s unique mode of action offers opportunities for research and exploration in the field of mitochondrial biology and metabolic pathways.
| Catalog Number | I012561 |
| CAS Number | 27031-00-1 |
| Synonyms | N-[4-(1H-Benzoimidazol-2-yl)-phenyl]-succinamic acid |
| Molecular Formula | C17H15N3O3 |
| Purity | ≥95% |
| IUPAC Name | 4-[4-(1H-benzimidazol-2-yl)anilino]-4-oxobutanoic acid |
| InChI | InChI=1S/C17H15N3O3/c21-15(9-10-16(22)23)18-12-7-5-11(6-8-12)17-19-13-3-1-2-4-14(13)20-17/h1-8H,9-10H2,(H,18,21)(H,19,20)(H,22,23) |
| InChIKey | ARVPDCQNTCJVSU-UHFFFAOYSA-N |
| SMILES | C1=CC=C2C(=C1)NC(=N2)C3=CC=C(C=C3)NC(=O)CCC(=O)O |
